1 / 16

Management

Management. Antiepileptic Drug Therapy Goal: completely prevent seizures without causing untoward side effects Treat the underlying conditions Reverse the problem and prevent its recurrence. Medical Management. Current Perspectives in Epilepsy Treatment: Focus on Monotherapy , 2006

chars
Télécharger la présentation

Management

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Management • Antiepileptic Drug Therapy • Goal: completely prevent seizures without causing untoward side effects • Treat the underlying conditions • Reverse the problem and prevent its recurrence

  2. Medical Management • Current Perspectives in Epilepsy Treatment: Focus on Monotherapy, 2006 • Initial treatment of epilepsy should begin with AED monotherapy • If initial trial fails, try monotherapy with a second AED • Combination therapy should be considered only if the patient fails at least 2 monotherapy trials Pellock, John, and Michael Privitera. Current Perspectives in Epilepsy Treatment: Focus on Monotherapy. CME Discovery, USA: ArcMesa Educators and Scinexa, LLC., 2006.

  3. Drugs of Choice for Adults with Partial Seizure • Phenytoin, carbamazepine, and valproateequally effective in the treatment of both generalized and partial seizures • Phenytoin • Idiosyncratic phenytoin hypersensitivity • similar therapeutic and side-effect profile with valproate • Carbamazepinepreferred as initial drug because of fewer side effects Ropper, Allan, and Robert Brown. Adams and Victor's Principles of Neurology. 8th. McGraw-Hill, 2005.

  4. Drug of Choice forElderly Adults with Partial-Onset Seizures • ILAE Treatment Guidelines, 2006 • Based on available efficacy and effectiveness evidence alone, LTG and GBP are established as efficacious or effective as initial monotherapy for elderly adults with newly diagnosed or untreated partial-onset seizures (level A) Glauser, T, ElinorBM, BlaiseBs,et. al. "ILAE Treatment Guidelines: Evidence-based Analysis of Antiepileptic Drug Efficacy and Effectiveness as Initial Monotherapy for Epileptic Seizures and Syndromes." (International League Against Epilepsy) 27, no. 7 (2006): 1094 -1120.

  5. Drug of Choice for Elderly Adults with Partial-Onset Seizures • ILAE Treatment Guidelines, 2006 • Class I Trial • Efficacy: CBZ = LTG and GBP • Effectiveness: LTG and GBP>> CBZ

  6. An International Multicenter Randomized Double-Blind Controlled Trial of Lamotrigine and Sustained-Release Carbamazepine in the Treatment of Newly Diagnosed Epilepsy in the Elderly (Satre, Erik, et al., 2007) • P: Patients aged 65 years or older, who had experienced at least two unprovoked partial and/or generalized tonic– clonic seizures • I: LTG (n = 93) or CBZ (n = 92) • 40-week treatment period: initial 4-week dose escalation phase and a 36-week maintenance phase

  7. An International Multicenter Randomized Double-Blind Controlled Trial of Lamotrigine and Sustained-Release Carbamazepine in the Treatment of Newly Diagnosed Epilepsy in the Elderly (Satre, Erik, et al., 2007) • O: • In the LTG group, 68 patients (73%) completed the 40-week study period compared with 61 (67%) in the CBZ group • Higher seizure-free rates for CBZ 46 (75%) than LTG 37 (54%) [OR=0.39, p=0.0129, CI 0.018 to 0.83] in the per-protocol analysis • Better tolerability for LTG where 13 patients (14%) withdrew due to AEs in the LTG group, compared with 23 (25%) in the CBZ group • M: Randomized Double-Blind Controlled Trial Saetre, Erik, et al. "An International Multicenter Randomized Double-Blind Controlled Trial of Lamotrigine and Sustained-Release Carbamazepine in the Treatment of Newly Diagnosed Epilepsy in the Elderly." Epilepsia 48.7 (2007): 1292-1302.

  8. Carbamazepine • Many side effects • Leukopenia is common • Rare instances of pancytopenia,hyponatremia, and diabetes insipidus as idiosyncratic reactions. • CBC should be done before treatment • white cell count should be checked regularly Ropper, Allan, and Robert Brown. Adams and Victor's Principles of Neurology. 8th. McGraw-Hill, 2005.

  9. Lamotrigine • Lamotrigine • closely resembles phenytoin • less risk of teratogeniceffects • selectively blocks the slow sodium channel  prevent release of glutamate and aspartate • effective as a first-line and adjunctive drug for generalized and focal seizure Ropper, Allan, and Robert Brown. Adams and Victor's Principles of Neurology. 8th. McGraw-Hill, 2005.

  10. Gabapentin • chemically similar to GABA • enhances the intrinsic inhibitory system of GABA in the brain • anticonvulsant mechanism is not known • moderately effective in partial and secondary generalized seizures • not metabolized by the liver Ropper, Allan, and Robert Brown. Adams and Victor's Principles of Neurology. 8th. McGraw-Hill, 2005.

  11. Carbamazepine vs. Lamotrigine

  12. Post-stroke Maintenance Medications • International Stroke Trial (IST, Lancet 1997;349:1569-1581) • Aspirin treated patients had slightly fewer deaths at 14 days, significantly fewer recurrent ischemic strokes at 14 days and no excess of hemorrhagic strokes

  13. Post-stroke Maintenance Medications Dipyridamole for Preventing Stroke and Other Vascular Events in Patients With Vascular Disease: An Update (Schryver, Algra and Gijn2008)

  14. Discontinuation of Anticonvulsants • Studies show that the rate of seizure recurrence after AED withdrawal is about two to three times the rate in patients who continue AEDs • ED discontinuation may be considered in patients whose seizures have been completely controlled for a prolonged period • 1 to 2 years for children&2 to 5 years for adults Hixson, John. "Stopping Antiepileptic Drugs." Current Treatment Options in Neurology (Springerlink), 12, no 5 (June 2010): 434-442.

  15. Discontinuation of Anticonvulsants • Factors such known to increase risk of recurrence • longer duration of epilepsy • an abnormal neurologic examination • an abnormal EEG • In patients with a favorable prognosis, risk of relapse can be as high as 20% to 25% • Before withdrawing AEDs, patients should be counseled about their individual risk for relapse and the potential implications of a recurrent seizure, particularly for safety and driving.

More Related